Effects of Acupuncture as Adjunctive Therapy in Patients With Type 2 Diabetes Mellitus

NCT04829045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-10-12

No results posted yet for this study

Summary

This study aims to determine the effect of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR) and health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus.

Conditions

  • Diabetes Mellitus, Type 2
  • Acupuncture

Interventions

DEVICE

SEIRIN PYONEX Acupuncture Needles

10 press needles (PYONEX ø0.20×1.5mm made by Seirin Corporation) will be placed on abdomen area; 10 sessions over 6 weeks.

OTHER

PYONEX Placebo

Subjects are given placebo on abdomen area; 10 sessions over 6 weeks.

Sponsors & Collaborators

  • Universiti Putra Malaysia

    lead OTHER

Principal Investigators

  • Cheok Yean Chin, MSc, OMBAcC · Universiti Putra Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-27
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04829045 on ClinicalTrials.gov